RepliCel Financial Statements From 2010 to 2024

Stocks . Canada . 
Stock . RepliCel Life Sciences
RP Stock  CAD 0.01  0.00  0.00%   
RepliCel Life financial statements provide useful quarterly and yearly information to potential RepliCel Life Sciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on RepliCel Life financial statements helps investors assess RepliCel Life's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting RepliCel Life's valuation are summarized below:
Gross Profit
353.7 K
Profit Margin
2.1572
Market Capitalization
735.8 K
Enterprise Value Revenue
2.104
Revenue
353.7 K
There are over one hundred nineteen available trending fundamental ratios for RepliCel Life Sciences, which can be analyzed over time and compared to other ratios. All traders should should check out RepliCel Life's recent fundamental trends against the trends from 2010 to 2024 to make sure the company is sustainable. Enterprise Value is likely to climb to about 8.4 M in 2024, whereas Market Cap is likely to drop slightly above 3.7 M in 2024.

RepliCel Life Total Revenue

437,105

Check RepliCel Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among RepliCel Life's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 K, Interest Expense of 156.6 K or Other Operating Expenses of 2.7 M, as well as many indicators such as Price To Sales Ratio of 10.34, Dividend Yield of 0.0 or Days Sales Outstanding of 34.68. RepliCel financial statements analysis is a perfect complement when working with RepliCel Life Valuation or Volatility modules.
  
This module can also supplement various RepliCel Life Technical models . Check out the analysis of RepliCel Life Correlation against competitors.

RepliCel Life Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets273.4 K287.8 K969.6 K
Pretty Stable
Short and Long Term Debt Total487.2 K813.2 K369.7 K
Very volatile
Total Current Liabilities1.9 M1.8 M1.1 M
Slightly volatile
Property Plant And Equipment Net91996711.7 K
Slightly volatile
Accounts Payable472.3 K416 K550.4 K
Slightly volatile
Cash56.2 K59.2 K493.7 K
Pretty Stable
Non Current Assets Total119.4 K125.7 K99.1 K
Slightly volatile
Cash And Short Term Investments72.6 K76.4 K698 K
Pretty Stable
Net Receivables39 K38 K45.4 K
Slightly volatile
Common Stock Shares Outstanding62.2 M59.2 M21.1 M
Slightly volatile
Liabilities And Stockholders Equity273.4 K287.8 K969.6 K
Pretty Stable
Other Stockholder Equity5.6 M5.6 M6.2 M
Pretty Stable
Total Liabilities5.1 M4.8 M2.8 M
Slightly volatile
Total Current Assets154 K162.1 K870.4 K
Pretty Stable
Common Stock20 M33.1 M20.9 M
Slightly volatile
Other Current Assets89.2 K47.7 K139.2 K
Slightly volatile
Accumulated Other Comprehensive Income555.2 K624.6 K680.1 K
Slightly volatile
Other Liabilities6.9 M6.6 M3.1 M
Slightly volatile
Property Plant Equipment2.8 K2.9 K13.2 K
Slightly volatile
Long Term Investments950.5 K973.1 K1.1 M
Slightly volatile
Current Deferred Revenue370.6 K406.8 K297.7 K
Slightly volatile
Inventory388.4 K436.9 K475.8 K
Slightly volatile
Capital Stock32.6 M36.4 M29.8 M
Slightly volatile
Non Current Liabilities Other1.6 M1.7 M2 M
Slightly volatile
Property Plant And Equipment Gross44.8 K50.4 K54.9 K
Slightly volatile
Long Term Debt38.1 K47.1 K31.8 K
Slightly volatile
Short and Long Term Debt37.8 K42.6 K46.4 K
Slightly volatile

RepliCel Life Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.4 K1.5 K4.4 K
Slightly volatile
Other Operating Expenses2.7 M1.7 M3.3 M
Pretty Stable
Total Operating Expenses2.6 M1.7 M3.3 M
Pretty Stable
Selling General Administrative1.5 M1.2 M2 M
Slightly volatile
Selling And Marketing Expenses472 K879.9 K686 K
Slightly volatile
Research Development500.1 K526.4 K1.2 M
Very volatile
Reconciled Depreciation1.6 K1.4 K3 K
Slightly volatile

RepliCel Life Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow490.4 K413 K600.2 K
Pretty Stable
Total Cash From Financing Activities1.8 M1.1 M2.2 M
Pretty Stable
End Period Cash Flow56.2 K59.2 K493.7 K
Pretty Stable
Depreciation1.4 K1.5 K4.2 K
Slightly volatile
Sale Purchase Of Stock4 M5.4 M3.6 M
Slightly volatile
Net Borrowings85.8 K96.6 K105.2 K
Slightly volatile
Issuance Of Capital Stock1.6 M2.2 M2 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio10.3410.885929.4738
Very volatile
Days Sales Outstanding34.6836.5005108
Very volatile
Average Payables274.5 K482.9 K397.1 K
Slightly volatile
Stock Based Compensation To Revenue0.720.68270.2514
Slightly volatile
Capex To Depreciation0.00220.00230.6064
Slightly volatile
EV To Sales20.4113.187223.4982
Very volatile
Sales General And Administrative To Revenue5.463.43077.5209
Very volatile
Research And Ddevelopement To Revenue1.411.48823.1489
Pretty Stable
Capex To Revenue0.00.05.0E-4
Slightly volatile
Cash Per Share0.00120.00130.0979
Slightly volatile
Current Ratio0.08450.08891.5119
Slightly volatile
Receivables Turnover9.59.999948.1134
Slightly volatile
Graham Number0.09040.09520.7317
Slightly volatile
Average Receivables55.5 K52.9 K46.4 K
Slightly volatile
Revenue Per Share0.00570.0060.2487
Slightly volatile
Interest Debt Per Share0.01640.01730.0217
Very volatile
Debt To Assets3.193.03421.2329
Slightly volatile
Ebt Per Ebit0.210.22491.1208
Pretty Stable
Quick Ratio0.08450.08891.4908
Slightly volatile
Cash Ratio0.03080.03250.8683
Slightly volatile
Days Of Sales Outstanding34.6836.5005108
Very volatile
Free Cash Flow Operating Cash Flow Ratio1.361.151.0431
Slightly volatile
Fixed Asset Turnover384366128
Slightly volatile
Debt Ratio3.193.03421.2329
Slightly volatile
Price Sales Ratio10.3410.885929.4738
Very volatile
Asset Turnover0.921.22920.8632
Slightly volatile

RepliCel Life Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap3.7 M3.9 M10.8 M
Slightly volatile
Enterprise Value8.4 M4.7 M10.6 M
Slightly volatile

RepliCel Fundamental Market Drivers

Cash And Short Term Investments76.4 K

About RepliCel Life Financial Statements

RepliCel Life investors use historical fundamental indicators, such as RepliCel Life's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in RepliCel Life. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue406.8 K370.6 K
Cost Of Revenue1.3 K1.3 K
Total Revenue318.4 K437.1 K
Stock Based Compensation To Revenue 0.68  0.72 
Sales General And Administrative To Revenue 3.43  5.46 
Research And Ddevelopement To Revenue 1.49  1.41 
Revenue Per Share 0.01  0.01 
Ebit Per Revenue(3.92)(4.11)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for RepliCel Stock Analysis

When running RepliCel Life's price analysis, check to measure RepliCel Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RepliCel Life is operating at the current time. Most of RepliCel Life's value examination focuses on studying past and present price action to predict the probability of RepliCel Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RepliCel Life's price. Additionally, you may evaluate how the addition of RepliCel Life to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY